26 news items
Updated Linvoseltamab Data Showcase Continued Deepening of Responses in Patients with Heavily Pre-Treated Multiple Myeloma
REGN
16 Jun 24
in the pivotal trial, 50% of patients achieved a complete response or better and a 71% overall response rate, as presented in an EHA oral presentation
Pancreatic Cancer on the Rise: How Biotech Firms are Developing Groundbreaking Treatments
CADL
FGEN
ONCY
12 Jun 24
yielded tumor response rates nearly triple historical results. Should the combination of pelareorep and mFOLFIRINOX produce a similarly positive
Pancreatic Cancer on the Rise: How Biotech Firms are Developing Groundbreaking Treatments
CADL
FGEN
ONCY
12 Jun 24
, and atezolizumab yielded tumor response rates nearly triple historical results. Should the combination of pelareorep and mFOLFIRINOX produce a similarly
Kevzara® (sarilumab) Approved by FDA for the Treatment of Active Polyarticular Juvenile Idiopathic Arthritis (pJIA)
REGN
11 Jun 24
rheumatic disease – in adult patients who have had an inadequate response to corticosteroids or who cannot tolerate corticosteroid taper
Navigating 14 Analyst Ratings For Regeneron Pharmaceuticals
REGN
4 Jun 24
they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Regeneron Pharmaceuticals
o8agtj0x6cqd9 hd3b4q6v6z2w3ksjo5q5xtg391ceopldid
REGN
31 May 24
treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility
nly3iwsofi94rpkeptrlsuobh97qq6j49 19njhecfjwfqmx4f1v8hnny
REGN
31 May 24
globally, while putting sustainability and social responsibility at the center of our ambitions. Sanofi is listed on EURONEXT: SAN
ogrsagxh7oqsoo0u6vzzb6689strhm
REGN
31 May 24
options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center
prbbo4
REGN
31 May 24
vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Sanofi
sjqiq70f9c9x1b 3h4ab0h2ykq399g9cre0
REGN
23 May 24
to anti-tumor responses in patients with microsatellite stable colorectal cancer (MSS CRC). REGN7075 is one of the first immunotherapies
ta2kejau97 h7yde
REGN
20 May 24
options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our
aewgmx6gc7gqpp32lwfoqx1yynl7e74izr47rwj7r2p0jq8cah1pwez8d3d
REGN
20 May 24
globally, while putting sustainability and social responsibility at the center of our ambitions. Sanofi is listed on EURONEXT: SAN
bnkp46ql922 85v
REGN
17 May 24
approach corporate responsibility with three goals in mind: to improve the lives of people with serious diseases, to foster a culture of integrity
5fylyzss8dxixomc5lxdjlxb6mjz3elwj6isbuvr
REGN
17 May 24
approach corporate responsibility with three goals in mind: to improve the lives of people with serious diseases, to foster a culture of integrity
20yhdabt
REGN
17 May 24
mission. We approach corporate responsibility with three goals in mind: to improve the lives of people with serious diseases, to foster a culture
vaesavij1q zey
REGN
13 May 24
and social responsibility at the center of our ambitions. Sanofi is listed on EURONEXT: SAN and NASDAQ: SNY. Regeneron Forward
z4wsvmdh15acj0d1inx8lx31dpy6b0 4upfqj9bfmfndpsz0990fjdgo0l0
REGN
8 May 24
is amenable for use in young infants. Hearing improvements were assessed by pure tone audiometry (PTA) and auditory brainstem response (ABR). PTA
9n7 b43vqixwoh
REGN
2 May 24
% objective response rate (ORR), with 46% of patients achieving a complete response (CR) or better.In March 2024, the FDA issued Complete Response
8u5rdqlyjaak1kdtjy29 rt4hq4q0f4
REGN
29 Apr 24
abnormal blood vessels grow and leak fluid under the macula, the part of the eye responsible for sharp central vision and seeing fine detail. This fluid
615wi3htqjskvcgct7tgt7p pspx6mo7t5z93q0yrctlhcry6jdvkhycy4
ABBV
REGN
SNY
25 Apr 24
daily starting dose and dose-adjusted based on clinical response) versus dupilumab (Dupixent, per its labeled dose